Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04440839 · ClinicalTrials.gov registry record · NA
Implementation of Telemedicine for Patient With Lower Extremity Wounds
A NA study of Peripheral Arterial Disease and Diabetic Foot Ulcer, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 116
- Enrollment target
- 1
- Study location
NCT04440839: Completed NA study of Peripheral Arterial Disease and Diabetic Foot Ulcer, sponsored by University of California, Davis.
NCT04440839 is a NA study of Peripheral Arterial Disease and Diabetic Foot Ulcer that has completed, run by University of California, Davis. The registered enrollment target is 116 participants, below the 4,205-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04440839, a NA study of Peripheral Arterial Disease and Diabetic Foot Ulcer, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to determine if patients with lower extremity wounds in rural communities who undergo specialty referral through telemedicine have expedited care compared to patients who are treated through standard in person referral.
Primary Outcome
The time from the date the wound is identified to the date of specialist consultation, in days.
Conditions Studied
Interventions
- OTHER Telemedicine specialty consultation
Study Locations (1)
California
- Misty D. Humphries - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2020-03-01 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT04440839 record still lists
NCT04440839 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 4,205-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (97% lower).
The record links to 7 conditions, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 1 intervention - of which Telemedicine specialty consultation is the first listed.
NCT04440839 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04440839 about?
NCT04440839 is a clinical study titled "Implementation of Telemedicine for Patient With Lower Extremity Wounds". The objective of this study is to determine if patients with lower extremity wounds in rural communities who undergo specialty referral through telemedicine have expedited care compared to patients who are treated through standard in person referral.
What is the current status of trial NCT04440839?
This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2020-03-01. Estimated completion is 2023-12-31.
What conditions does trial NCT04440839 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease, Diabetic Foot Ulcer, Peripheral Artery Disease, Diabetic Foot, Peripheral Vascular Diseases.
What interventions are being tested in trial NCT04440839?
The interventions under investigation include: Telemedicine specialty consultation (OTHER).
Who is sponsoring clinical trial NCT04440839?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04440839 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04440839's enrollment target sits among peer trials
116 35th of 79 higher than 45 of 79 other Peripheral Arterial Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peripheral Arterial Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SELUTION4BTK Trial
RECRUITING · NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
RECRUITING · NA
-
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
RECRUITING · NA
-
Prehabilitation and Rehabilitation in PAD
RECRUITING · NA
-
Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy
RECRUITING · NA
-
Assessment of the Utility of the Pantheris Small Vessel (SV) System
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI